Mulay James
SEC CIK 1684531 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Dir | 24.2K | — | $6.28M | 18 | 2025-09-05 | 2026-07-10 |
Most active insiders at CGON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Liu Brian Guan-Chyun | Dir | $24.81M | — |
| 2 | Mulay James | Dir | — | $4.54M |
| 3 | POST LEONARD E | Dir | — | $1.23M |
| 4 | Kuan Arthur | CEO, Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-14 16:15 | 2026-07-10 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $26.63 | +24.2K | 24.2K | New | +$643.5K |
| DT | 2026-07-14 16:15 | 2026-07-10 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $75.16 | -24.2K | 0 | -100% | -$1.82M |
| DMT | 2026-06-16 17:07 | 2026-06-15 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $9.64 | +1,964 | 1,310 | New | +$18.9K |
| DMT | 2026-06-16 17:07 | 2026-06-15 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $60.12 | -1,964 | 0 | -100% | -$118.1K |
| DT | 2026-04-20 16:15 | 2026-04-17 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $36.63 | +15.6K | 15.6K | New | +$571.4K |
| DT | 2026-04-20 16:15 | 2026-04-17 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $73.01 | -15.6K | 0 | -100% | -$1.14M |
| DMT | 2026-03-17 | 2026-03-16 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $9.64 | +1,964 | 654 | New | +$18.9K |
| DMT | 2026-03-17 | 2026-03-16 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $63.50 | -1,964 | 0 | -100% | -$124.7K |
| DMT | 2026-01-13 | 2026-01-09 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $52.47 | -11.1K | 0 | -100% | -$584.8K |
| DMT | 2026-01-13 | 2026-01-09 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $12.07 | +11.1K | 10.5K | New | +$134.5K |
| DT | 2025-10-10 | 2025-10-09 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $43.99 | -5,903 | 0 | -100% | -$259.7K |
| DT | 2025-10-10 | 2025-10-09 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $3.72 | +5,903 | 5,903 | New | +$22.0K |
| DT | 2025-09-30 | 2025-09-29 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $1.82 | +12.8K | 12.8K | New | +$23.2K |
| DT | 2025-09-30 | 2025-09-29 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $39.19 | -12.8K | 0 | -100% | -$499.9K |
| DMT | 2025-09-22 | 2025-09-18+ | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $1.82 | +22.7K | 3,574 | New | +$41.3K |
| DMT | 2025-09-22 | 2025-09-18+ | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $39.01 | -22.7K | 0 | -100% | -$884.9K |
| DMT | 2025-09-08 | 2025-09-05 | CGON | CG Oncology, Inc. | Mulay James | Dir | S - Sale+OE | $31.53 | -27.0K | 14.7K | -65% | -$851.8K |
| DT | 2025-09-08 | 2025-09-05 | CGON | CG Oncology, Inc. | Mulay James | Dir | M - OptEx | $0.6 | +27.0K | 27.0K | New | +$16.2K |
Purchase Sale Sale after option exercise All abbreviations